GuidelinesTesting data2026.10.03
Sterile Packaging Validation: Connect Package Tests With Sealing-Process Evidence
Protection must continue after sterilization until use. Connect material selection, sealing, distribution, aging and aseptic opening within one evidence plan.
Separate sterilization from packaging-system performance
Evidence that a product underwent sterilization differs from evidence that its protected state is maintained until use. Consider projections, weight, materials and packaging construction together. The same pouch with different contents can experience different pressure, abrasion, puncture and opening conditions.
ISO 11607-1 addresses materials, sterile barriers and packaging systems for terminally sterilized devices; Part 2 addresses forming, sealing and assembly-process validation. Do not extend that scope indiscriminately to aseptically manufactured products. Confirm Korean requirements and editions, and where relevant review the sterile Class I and KGMP guide.
Fix the packaging configuration before testing
Identify pouch or tray materials, thickness, size, coatings, suppliers and sealing surfaces. Include labels, protective inserts and outer cartons as shipped. Changes in orientation, quantity or arrangement inside transport packaging can affect whether results represent the actual configuration.
The sterilization method and allowed exposure range are design inputs. Assess possible effects of heat, humidity, radiation or other exposures on materials and joints. A supplier’s general compatibility statement needs comparison with actual processing conditions. Keep traceable manufacturing, sealing and sterilization histories for test samples.
Plan package performance and process evidence separately
Use this table to frame the laboratory discussion; it is not a universal method or sample-size specification.
| Question | Evidence to prepare |
|---|---|
| Are materials suitable? | Specifications, sterilization compatibility, product interactions |
| Is the barrier maintained? | Integrity assessment appropriate to construction and its detection limits |
| Can seals be made consistently? | Equipment, variable ranges, work conditions and validation |
| Is protection retained after distribution? | Configuration and evaluation representing the route |
| Can the package be opened appropriately? | Opening method, presentation of contents and related use risks |
High seal strength does not answer every leakage question. Integrity results alone do not explain every tearing or contamination risk during opening. State what each evaluation does and does not establish.
Base distribution and aging sequences on the use pathway
Map the order of sterilization, storage, shipping and opening. Explain how the test sequence represents that pathway, and define initial and post-treatment evaluations. Laboratory convenience alone is not an adequate explanation of sample representativeness.
Aged-package performance does not automatically establish device performance or material stability. Shelf-life claims need consideration of limiting factors in both product and package. Justify samples and representative models using contents, damage potential and test characteristics as well as package dimensions.
Transfer sealing conditions into production controls
Define relevant variables—such as temperature, pressure and time—and their operating ranges. Confirm how settings relate to measured values and whether measurement and calibration are appropriate. The ranges evaluated through OQ/PQ must agree with the instructions used by operators.
Define segregation after a defective seal, the last known acceptable checkpoint, possible rework and approval rules. Design appropriate checks for shift or material-lot changes and restart after downtime. Link these controls to the KGMP preparation guide.
Reassess the scope after supplier or size changes
Materials sold under the same name can differ in structure, coating or tolerances. Evaluate changes in supplier, dimensions, sealing equipment and sterilization exposure against the existing conclusions. Identify which assumptions changed before deciding the necessary extent of retesting.
Bring specifications, photographs of the shipped configuration, sealing settings, sterilization details and the shelf-life plan to a sterile-packaging evidence review. Together they distinguish what material reports establish from what still needs finished-package and process evidence.
Sources checked: 2026-09-28. The tables and preparation steps are practical suggestions; confirm the legal submission scope and applicable standards for the particular product.
Frequently asked questions
- Q. Does successful sterilization eliminate packaging testing?
- No. Sterilization effectiveness and maintenance of protection until use are separate questions. Connect evidence for the product, package and sterilization method.
- Q. Is seal-strength testing sufficient?
- It answers one question. Depending on construction and risk, consider integrity, post-distribution and aging performance, and opening-related use issues.
- Q. Can supplier material reports be used?
- They can support material properties, but do not automatically establish the finished system’s suitability under actual product, sealing, sterilization and distribution conditions.